FDA Import Refusal SCS-0200173-6/21/2 — Reckitt Banckiser Plc
The FDA refused shipment SCS-0200173-6/21/2 from Reckitt Banckiser Plc (United Kingdom) on Mar 10, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,336,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 10, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,336,75